Regency Lifesciences (India) Private Limited

Medical device and equipment trading for healthcare industry.

2009 | Bangaluru, Karnataka (India) | Active
Last Updated:

Regency Lifesciences (India) Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 15 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.50 M
  • Revenue Growth 31.24%
  • Profit Growth 25.63%
  • Ebitda 20.01%
  • Net Worth 32.07%
  • Total Assets -2.88%

About Regency Lifesciences (India)

Regency Lifesciences (India) Private Limited (RLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 December 2009 and has a history of 15 years and two months. Its registered office is in Bangaluru, Karnataka, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.

The company currently has active open charges totaling ₹5.50 M.

Abel Alexander, Balu Durgaprasad, and Jeslet Abel serve as directors at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231KA2009PTC051931

  • Company No.

    051931

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    23 Dec 2009

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Healthcare

Who are the key members and board of directors at Regency Lifesciences (India)?

Executive Team (1)

NameDesignationAppointment DateStatus
Abel Alexander Country flag representing In Managing Director23-Dec-2009Current

Board Members (2)

NameDesignationAppointment DateStatus
Balu Durgaprasad Country flag representing In Director 02-Jan-2015Current
Jeslet Abel Country flag representing In Director 28-Jun-2019Current

Financial Performance of Regency Lifesciences (India).

Regency Lifesciences (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.24% increase. The company also saw a substantial improvement in profitability, with a 25.63% increase in profit. The company's net worth Soared by an impressive increase of 32.07%.

Regency Lifesciences (India) revenue growth over time
Regency Lifesciences (India) profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
31.24%
Revenue from Operations
31.26%
Total Assets
-2.88%
Profit or Loss
25.63%
Net Worth
32.07%
EBITDA
20.01%

What is the Ownership and Shareholding Structure of Regency Lifesciences (India)?

In 2022, Regency Lifesciences (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹5.50 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Indian Overseas Bank : 0.55 Cr

Latest Charge Details

DateLenderAmountStatus
04 Oct 2022Indian Overseas Bank₹5.50 MOpen

How Many Employees Work at Regency Lifesciences (India)?

Unlock and access historical data on people associated with Regency Lifesciences (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Regency Lifesciences (India) Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Regency Lifesciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regency Lifesciences (India)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Regency Lifesciences (India)

Recent activity within the organization

  • Annual General Meeting

    Regency Lifesciences (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Regency Lifesciences (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

  • Charges

    A charge with Indian Overseas Bank amounted to Rs. 5.50 M with Charge ID 100622623 was registered on 04 Oct 2022.

  • Director Appointment

    Jeslet Abel was appointed as a Director was appointed as a Director on 28 Jun 2019 & has been associated with this company since 5 years 8 months .

  • Director Appointment

    Balu Reddy Durgaprasad was appointed as a Director was appointed as a Director on 02 Jan 2015 & has been associated with this company since 10 years 2 months .

  • Director Appointment

    Abel Boodala Alexander was appointed as a Managing Director was appointed as a Managing Director on 23 Dec 2009 & has been associated with this company since 15 years 2 months .

Frequently asked questions

  • What is the Incorporation or founding date of Regency Lifesciences (India) Private Limited?

    Regency Lifesciences (India) Private Limited was incorporated on 23 Dec 2009.

  • What is authorized share capital and paid-up capital of Regency Lifesciences (India) Private Limited?

    The authorized share capital of Regency Lifesciences (India) Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.

  • Who are the current board members & directors of Regency Lifesciences (India) Private Limited?

    Currently 3 directors are associated with Regency Lifesciences (India) Private Limited.

    • Abel Boodala Alexander
    • Balu Reddy Durgaprasad
    • Jeslet Abel
  • What is the registered address of Regency Lifesciences (India) Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Regency Lifesciences (India) Private Limited is No.118/5 Hennur Main Road Kacharakanahalli, St Thomas Town Post India, Bangalore, Karnataka, 560084.

  • What is the corporate identification number (CIN) and company number of Regency Lifesciences (India) Private Limited?

    The corporate identification number (CIN) of Regency Lifesciences (India) Private Limited is U24231KA2009PTC051931 and the company number is 051931 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Regency Lifesciences (India) Private Limited?

    The Official website of Regency Lifesciences (India) Private Limited is https://www.regencylifesciences.com

  • What has been the recent revenue trend for Regency Lifesciences (India) Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Regency Lifesciences (India) Private Limited has risen by 31.24%.

  • What change has been observed in the net worth of Regency Lifesciences (India) Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Regency Lifesciences (India) Private Limited has experienced an upsurge of 32.07%.

  • What are the total open charges for Regency Lifesciences (India) Private Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Regency Lifesciences (India) Private Limited amount to ₹ 5.50 M.

  • When was the last Balance Sheet of Regency Lifesciences (India) Private Limited filed with the ROC?

    The most recent Balance Sheet for Regency Lifesciences (India) Private Limited was filed with the ROC on 31 Mar 2024.